WPI 3721 (Lamotrigine (Orally Disintegrating) 25 mg)
Pill with imprint WPI 3721 is White, Round and has been identified as Lamotrigine (Orally Disintegrating) 25 mg. It is supplied by Global Pharmaceuticals.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3721

Lamotrigine (Orally Disintegrating)
- Imprint
- WPI 3721
- Strength
- 25 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Global Pharmaceuticals
- National Drug Code (NDC)
- 00115-1526 (Discontinued)
- Inactive Ingredients
-
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
aspartame,
silicon dioxide,
crospovidone,
magnesium stearate,
mannitol,
microcrystalline cellulose,
corn starch,
sodium chloride,
stearic acid
Note: Inactive ingredients may vary.
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,552)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.